Document is current
Any future updates will be listed below
-
Authors
Masi, Paul
Abrams, Darryl
Hssain, Ali Ait
Balik, Martin
Barrett, Nicholas A.
Broman, Lars Mikael
Camporota, Luigi
Chen, Yih-Sharng
Combes, Alain
De Backer, Daniel
Del Sorbo, Lorenzo
Diaz, Rodrigo
Donker, Dirk W.
Douflé, Ghislaine
Fan, Eddy
Fraser, John F.
Giani, Marco
Giraud, Raphael
Grasselli, Giacomo
Hraiech, Sami
Lorusso, Roberto
MacLaren, Graeme
Marcus, Joseph E.
Martucci, Gennaro
Mendes, Pedro Vitale
Ohshimo, Shinichiro
Paiva, José-Artur
Park, Sunghoon
Ramanathan, Kollengode
Riera, Jordi
Roncon-Albuquerque, Roberto Jr.
Salazar, Leonardo
Schmidt, Matthieu
Shah, Aditya
Shekar, Kiran
Supady, Alexander
Taccone, Fabio Silvio
Tonna, Joseph E.
Yeung Ng, Pauline
Yusuff, Hakeem
Luyt, Charles-Edouard https://orcid.org/0000-0001-7424-2705
,
- License Information
-
More Information
Article History
Received: 2 October 2025
Accepted: 15 December 2025
First Online: 8 January 2026
Declarations
:
: LMB is Advisor for Eurosets and HemoCue. EF reports personal fees from Aerogen, Baxter, Boehringer Ingelheim, Getinge, Inspira, Mallinckrodt, and Vasomine outside the submitted work. GG received payment for lectures from Getinge, Draeger, Fisher&Paykel, Mundipharma, Pfizer, Jafron; payment advisory board participation from GSK, Viatris; research grants from Fisher&Paykel, Pfizer, MSD. SH received lecture fees from Shionogi, Pfizer, MSD and Biomérieux. MS reports lecture fees from Getinge and Solventum, he is the coordinating investigator of the DRESSING-ECMO trial (NCT05750576). FST is Advisor for Eurosets and Xenios. CEL received lecture fees Merck, AdvanzPharma and Shionoghi, travel grant from Pfizer and grant from Eumedica, all outside the submitted work. Other authors have no conflict of interest to disclose.
: Not applicable.
: Not applicable.
: Not applicable.
